Walmart reported solid fourth-quarter results Thursday behind higher US sales, but shares tumbled after its quarterly and ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Australia’s pharmaceutical sector is preparing for US President ­Donald Trump’s latest round of flagged tariffs to hit at ...

Organon & Co. (NYSE:OGN), a global healthcare company spun off from Merck (NSE:PROR) in 2021, has established itself as a leader in women's health while expanding its presence in biosimilars and ...

McIntyre Partnerships, an investment management company released its fourth quarter investor letter. McIntyre Partnerships ...

Telix Pharmaceuticals posted a big jump in profits during the 2024 financial year, as sales of its prostate cancer diagnostic ...

The Massachusetts Fiscal Alliance is slamming Gov. Maura Healey’s proposal to resurrect a long-dormant tax on prescription ...

Kerley, group vice president, pharmacy growth and clinical programs at Rite Aid, shares how the retailer's expanding ...

US retail sales slumped in January by the most in nearly two years, indicating an abrupt pullback by consumers after a spending spree in the closing months of 2024. The value of retail purchases ...

Business leaders and medical professionals from around the Tri-State turned out to celebrate the Business Courier’s 2025 ...

Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS Secretary.